Pharmacokinetics of Amikacin During Hemodialysis and Peritoneal Dialysis
The pharmacokinetics of amikacin were examined in six bilaterally nephrectomized patients undergoing hemodialysis and in four patients with a minimal residual renal function undergoing peritoneal dialysis. The mean elimination half-life before the dialysis was 86.5 h in the anephric patients and 44....
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1977
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351955/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/848923/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.2.214 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|